| Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia. | |
| | |
MedLine Citation:
|
PMID: 2196353 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To test the hypothesis that alternate-day administration of furosemide will result in a sustained improvement in pulmonary function without causing alterations in electrolyte or mineral homeostasis, we conducted a randomized, double-blind, placebo-controlled study of 11 hospitalized, oxygen-dependent, spontaneously breathing infants with chronic bronchopulmonary dysplasia. Infants were randomly selected to receive either furosemide, 4 mg/kg in two divided doses on alternate days orally, or placebo for 8 days, followed by crossover to the alternate-therapy for an additional 8-day period. The two study periods were separated by a 48-hour washout period. Dynamic compliance, total pulmonary resistance, the concentration of electrolytes in serum, and the concentrations of calcium and creatinine in urine were measured on nontreatment days. Alternate-day furosemide therapy increased dynamic lung compliance by 76 +/- 112% and decreased total pulmonary resistance by 20 +/- 39%, compared with placebo (both variables p = 0.032). Alternate-day furosemide therapy did not result in increased urine output, electrolyte abnormalities, or increased urinary calcium excretion. We conclude that this simplified treatment regimen may be useful in the management of infants with chronic bronchopulmonary dysplasia. The results support our previous speculation that furosemide improves pulmonary function by mechanisms unrelated to its diuretic properties. |
| | |
Authors:
|
M G Rush; B Engelhardt; R A Parker; T A Hazinski |
Related Documents
:
|
16598083 - Acetabular morphometry for determining hip dysplasia in the singaporean population. 16107873 - Rehospitalization of extremely low birth weight (elbw) infants: are there racial/ethnic... 3140403 - Enteral nutrition does not prevent multiple organ failure syndrome (mofs) after sepsis. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of pediatrics Volume: 117 ISSN: 0022-3476 ISO Abbreviation: J. Pediatr. Publication Date: 1990 Jul |
Date Detail:
|
Created Date: 1990-08-17 Completed Date: 1990-08-17 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375410 Medline TA: J Pediatr Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 112-8 Citation Subset: AIM; IM |
Affiliation:
|
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Airway Resistance
/
drug effects Bronchopulmonary Dysplasia / blood, drug therapy*, urine Calcium / urine Chronic Disease Clinical Trials as Topic Double-Blind Method Esophagus / physiology Furosemide / administration & dosage, therapeutic use* Humans Infant Infant, Newborn Lung Compliance / drug effects Oxygen / blood Placebos Pressure Pulmonary Ventilation / drug effects Random Allocation Respiratory Mechanics / drug effects Tidal Volume / drug effects |
| Grant Support | |
ID/Acronym/Agency:
|
HL07256/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Placebos; 54-31-9/Furosemide; 7440-70-2/Calcium; 7782-44-7/Oxygen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Natural killer cells in cutaneous malignant melanoma.
Next Document: Frequent handling in the neonatal intensive care unit and intraventricular hemorrhage.